Privi Speciality Chemicals
Stock Snapshot
Price Performance
Vista Outlook
View Technicals Analysis →Basis of our Recommendation
Privi Speciality Chemicals is poised for growth, driven by management's strategic focus on capacity expansion and backward integration, particularly in the aroma chemicals segment. The company's 'China+1' strategy aims to reduce reliance on Chinese supply chains, enhancing its competitive position. Recent management commentary indicates confidence in achieving long-term revenue targets of INR 50 billion and EBITDA of INR 10 billion, supported by a robust pipeline of new products and a joint venture with Givaudan. Vista's financial outlook reflects moderate revenue growth expectations, stable margins, and a fair valuation, with a target price of INR 4,167.86 for the next 12 months. The specialty chemicals industry is experiencing structural growth, bolstered by increasing demand for sustainable ingredients, although competitive pricing pressures remain a concern. Over the next 12-24 months, key opportunities include the successful commercialization of new specialty products and the benefits from the proposed corporate amalgamation. However, watchpoints include raw material price volatility and execution risks associated with capacity expansions
Why We Like This Stock
- Management's strategic roadmap emphasizes capacity expansion and backward integration, enhancing competitive resilience
- The joint venture with Givaudan is expected to significantly boost sales and diversify the product portfolio
- Strong demand for sustainable ingredients positions Privi favorably within the expanding specialty chemicals market
Things To Watch Out For
- Raw material price volatility poses a risk to margins and operational stability
- Execution challenges in managing growth and project timelines could impact revenue targets
- Intense competition in the specialty chemicals sector may pressure pricing and market share
Key Parameters
Financial Snapshot
| Actuals | Forecast | ||||
|---|---|---|---|---|---|
| FY24 | FY25 | FY26 | FY27 | FY28 | |
| Revenue (Cr.) | 1,752 | 2,101 | 2,564 | 2,650 | 3,078 |
| Profit Before Tax (Cr.) | 126 | 254 | 440 | 524 | 593 |
| PBT Margin | 7.2% | 12.1% | 1716.1% | 19.8% | 19.3% |
| Net Profit (Cr.) | 95 | 185 | 315 | 375 | 409 |
| Earnings Per Share | 24.1 | 47.9 | 83.3 | 92.5 | 104.7 |
Analyst Recommendations
| Broker | Recommendation | Target Price | Date |
|---|---|---|---|
| Motilal Oswal | ▲ Buy | 4,400 | 31-Jul-2026 |
Company Overview
Show Company Profile
Privi Speciality Chemicals Limited engages in the manufacture, supply, and export of aroma and fragrance chemicals in India, North America, Asia, the Middle East, Africa, Europe, South America, and the United Kingdom. It offers a range of aroma chemicals, including alpha damascone, alpha ionone, alpha terpenyl acetate, amber fleur, amber gamma, beta iso damascol, BI perfumery grade, BI technical grade, carene-60 and carene-90, carvacrol, cedar ketol, citronellal, citronellol, citronellyl acetate, citronellyl nitrile, dipentene, double distilled turpentine oil, dihydro myrcenol, dihydromyrcene, galaxmusk, gamma methyl ionone, gamma terpenyl acetate, geraniol, geranyl acetate, Indian sandal core, ionone, iso boronyl acetate, isobornyl cyclohexanol, l-limonene, methyl ionone, nerol, neryl acetate, nimberol, OTBCHA, pine oil, prionyl, PTCBH, PTBCHA, rose oxide, sandal fleur, terpeniol alpha, terpeniol gamma, terpeniol BP grade, terpinolene, tetrahydroflorol, tetrahydrogeraniol, tetrahydrogeranyl acetate, tetrahydromyrcenol, timber forte, timber touch, eucalyptol, cineole, cyclademol, cyclamen aldehyde, indomeran, floravone, ambery woody extreme, camphor, and iso borneol commercial. The company was formerly known as Fairchem Speciality Limited and changed its name to Privi Speciality Chemicals Limited in October 2020. Privi Speciality Chemicals Limited was incorporated in 1985 and is based in Mumbai, India.